Abstract
Purpose To present the management options for vitreomacular traction (VMT) and to recommend an individualized approach to treatment selection. Design Presented at the American Academy of Ophthalmology Annual Meeting, 2016, Chicago, October 15, 2016 (The Charles Schepens Lecture). Participants None. Methods Review of published literature and clinical trials. Main Outcome Measures Visual and anatomic outcomes of various treatment options for VMT were reviewed. Results The management options for VMT include pars plana vitrectomy, pneumatic vitreolysis, enzymatic vitreolysis, and observation. The surgical management using pars plana vitrectomy offers the most effective approach for VMT, but there are inherent risks and cost issues. Pneumatic vitreolysis is reported to be cost-effective and may be an anatomically successful nonsurgical option for management. Enzymatic vitreolysis with intravitreal ocriplasmin is another nonsurgical option, but both short- and long-term side effects may occur. Observation in selected patients can be associated with stable visual outcomes during long-term follow-up. Conclusions The final management decision should be individualized for specific patients depending on the patient's clinical findings, potential risks, probable benefits, and costs of each option.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 3-7 |
| Number of pages | 5 |
| Journal | Ophthalmology Retina |
| Volume | 1 |
| Issue number | 1 |
| DOIs | |
| State | Published - Jan 1 2017 |
Fingerprint
ASJC Scopus subject areas
- Ophthalmology
Cite this
The Charles Schepens Lecture : Management Options for Vitreomacular Traction: Use an Individualized Approach. / Flynn, Harry W; Relhan, Nidhi.
In: Ophthalmology Retina, Vol. 1, No. 1, 01.01.2017, p. 3-7.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - The Charles Schepens Lecture
T2 - Management Options for Vitreomacular Traction: Use an Individualized Approach
AU - Flynn, Harry W
AU - Relhan, Nidhi
PY - 2017/1/1
Y1 - 2017/1/1
N2 - Purpose To present the management options for vitreomacular traction (VMT) and to recommend an individualized approach to treatment selection. Design Presented at the American Academy of Ophthalmology Annual Meeting, 2016, Chicago, October 15, 2016 (The Charles Schepens Lecture). Participants None. Methods Review of published literature and clinical trials. Main Outcome Measures Visual and anatomic outcomes of various treatment options for VMT were reviewed. Results The management options for VMT include pars plana vitrectomy, pneumatic vitreolysis, enzymatic vitreolysis, and observation. The surgical management using pars plana vitrectomy offers the most effective approach for VMT, but there are inherent risks and cost issues. Pneumatic vitreolysis is reported to be cost-effective and may be an anatomically successful nonsurgical option for management. Enzymatic vitreolysis with intravitreal ocriplasmin is another nonsurgical option, but both short- and long-term side effects may occur. Observation in selected patients can be associated with stable visual outcomes during long-term follow-up. Conclusions The final management decision should be individualized for specific patients depending on the patient's clinical findings, potential risks, probable benefits, and costs of each option.
AB - Purpose To present the management options for vitreomacular traction (VMT) and to recommend an individualized approach to treatment selection. Design Presented at the American Academy of Ophthalmology Annual Meeting, 2016, Chicago, October 15, 2016 (The Charles Schepens Lecture). Participants None. Methods Review of published literature and clinical trials. Main Outcome Measures Visual and anatomic outcomes of various treatment options for VMT were reviewed. Results The management options for VMT include pars plana vitrectomy, pneumatic vitreolysis, enzymatic vitreolysis, and observation. The surgical management using pars plana vitrectomy offers the most effective approach for VMT, but there are inherent risks and cost issues. Pneumatic vitreolysis is reported to be cost-effective and may be an anatomically successful nonsurgical option for management. Enzymatic vitreolysis with intravitreal ocriplasmin is another nonsurgical option, but both short- and long-term side effects may occur. Observation in selected patients can be associated with stable visual outcomes during long-term follow-up. Conclusions The final management decision should be individualized for specific patients depending on the patient's clinical findings, potential risks, probable benefits, and costs of each option.
UR - http://www.scopus.com/inward/record.url?scp=85062395446&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85062395446&partnerID=8YFLogxK
U2 - 10.1016/j.oret.2016.09.006
DO - 10.1016/j.oret.2016.09.006
M3 - Article
AN - SCOPUS:85062395446
VL - 1
SP - 3
EP - 7
JO - Ophthalmology Retina
JF - Ophthalmology Retina
SN - 2468-7219
IS - 1
ER -